Literature DB >> 22452578

Critical role of truncated α-synuclein and aggregates in Parkinson's disease and incidental Lewy body disease.

Kavita Prasad1, Thomas G Beach, John Hedreen, Eric K Richfield.   

Abstract

The role of Lewy bodies, Lewy neurites and α-synuclein (αSYN) in the pathophysiology and diagnosis of Parkinson's disease (PD) is unclear. We used postmortem human tissue, a panel of antibodies (Abs) and confocal microscopy to examine the three-dimensional neurochemical anatomy of the nigrostriatal system. Abs were specific to truncated (tαSYN), phosphorylated and full-length αSYN. The findings demonstrate the critical role of tαSYN in initiating aggregation, a role for other forms of αSYN in aggregate expansion, a reason for the wide variety of proteins present in different aggregates, an explanation for the laminar appearance of aggregates described historically using different methods, the existence of proximal greater than distal aggregation in the vulnerable nigrostriatal pathway, the independent transport of different forms of αSYN as cargo along axons and a possible sequence for the formation of Lewy bodies. Findings differed between incidental Lewy body disease and PD only quantitatively. These findings have implications for understanding the pathogenesis and treatment of PD.
© 2012 The Authors; Brain Pathology © 2012 International Society of Neuropathology.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22452578      PMCID: PMC5505643          DOI: 10.1111/j.1750-3639.2012.00597.x

Source DB:  PubMed          Journal:  Brain Pathol        ISSN: 1015-6305            Impact factor:   6.508


  58 in total

1.  Relationships between Lewy bodies and pale bodies in Parkinson's disease.

Authors:  G E Dale; A Probst; P Luthert; J Martin; B H Anderton; P N Leigh
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

2.  Abnormal neurites containing C-terminally truncated alpha-synuclein are present in Alzheimer's disease without conventional Lewy body pathology.

Authors:  Karen A Lewis; Yang Su; Olina Jou; Caroline Ritchie; Chan Foong; Linda S Hynan; Charles L White; Philip J Thomas; Kimmo J Hatanpaa
Journal:  Am J Pathol       Date:  2010-11-05       Impact factor: 4.307

3.  Concentric hyalin intraneuronal inclusions of Lewy type in the brains of elderly persons (50 incidental cases): relationship to parkinsonism.

Authors:  L S Forno
Journal:  J Am Geriatr Soc       Date:  1969-06       Impact factor: 5.562

4.  Parkinson's disease. Genetic analysis and evidence of a multifactorial etiology.

Authors:  K Kondo; L T Kurland; W J Schull
Journal:  Mayo Clin Proc       Date:  1973-07       Impact factor: 7.616

5.  Defining the Parkinson's disease phenotype: initial symptoms and baseline characteristics in a clinical cohort.

Authors:  Ryan J Uitti; Yasuhiko Baba; Zbigniew K Wszolek; D John Putzke
Journal:  Parkinsonism Relat Disord       Date:  2005-05       Impact factor: 4.891

6.  Proteomic identification of novel proteins in cortical lewy bodies.

Authors:  James B Leverenz; Imran Umar; Qing Wang; Thomas J Montine; Pamela J McMillan; Debby W Tsuang; Jinghua Jin; Catherine Pan; Jenny Shin; David Zhu; Jing Zhang
Journal:  Brain Pathol       Date:  2007-04       Impact factor: 6.508

7.  Etiology of Parkinson's disease.

Authors:  Anthony H V Schapira
Journal:  Neurology       Date:  2006-05-23       Impact factor: 9.910

8.  Incidence of Parkinson's disease: variation by age, gender, and race/ethnicity.

Authors:  Stephen K Van Den Eeden; Caroline M Tanner; Allan L Bernstein; Robin D Fross; Amethyst Leimpeter; Daniel A Bloch; Lorene M Nelson
Journal:  Am J Epidemiol       Date:  2003-06-01       Impact factor: 4.897

Review 9.  Oxidative stress as a cause of nigral cell death in Parkinson's disease and incidental Lewy body disease. The Royal Kings and Queens Parkinson's Disease Research Group.

Authors:  P Jenner; D T Dexter; J Sian; A H Schapira; C D Marsden
Journal:  Ann Neurol       Date:  1992       Impact factor: 10.422

10.  The Sun Health Research Institute Brain Donation Program: description and experience, 1987-2007.

Authors:  Thomas G Beach; Lucia I Sue; Douglas G Walker; Alex E Roher; LihFen Lue; Linda Vedders; Donald J Connor; Marwan N Sabbagh; Joseph Rogers
Journal:  Cell Tissue Bank       Date:  2008-03-18       Impact factor: 1.522

View more
  21 in total

1.  Physiological C-terminal truncation of α-synuclein potentiates the prion-like formation of pathological inclusions.

Authors:  Zachary A Sorrentino; Niran Vijayaraghavan; Kimberly-Marie Gorion; Cara J Riffe; Kevin H Strang; Jason Caldwell; Benoit I Giasson
Journal:  J Biol Chem       Date:  2018-10-16       Impact factor: 5.157

Review 2.  The emerging role of α-synuclein truncation in aggregation and disease.

Authors:  Zachary A Sorrentino; Benoit I Giasson
Journal:  J Biol Chem       Date:  2020-05-18       Impact factor: 5.157

3.  Arizona Study of Aging and Neurodegenerative Disorders and Brain and Body Donation Program.

Authors:  Thomas G Beach; Charles H Adler; Lucia I Sue; Geidy Serrano; Holly A Shill; Douglas G Walker; LihFen Lue; Alex E Roher; Brittany N Dugger; Chera Maarouf; Alex C Birdsill; Anthony Intorcia; Megan Saxon-Labelle; Joel Pullen; Alexander Scroggins; Jessica Filon; Sarah Scott; Brittany Hoffman; Angelica Garcia; John N Caviness; Joseph G Hentz; Erika Driver-Dunckley; Sandra A Jacobson; Kathryn J Davis; Christine M Belden; Kathy E Long; Michael Malek-Ahmadi; Jessica J Powell; Lisa D Gale; Lisa R Nicholson; Richard J Caselli; Bryan K Woodruff; Steven Z Rapscak; Geoffrey L Ahern; Jiong Shi; Anna D Burke; Eric M Reiman; Marwan N Sabbagh
Journal:  Neuropathology       Date:  2015-01-26       Impact factor: 1.906

4.  Revisiting the specificity and ability of phospho-S129 antibodies to capture alpha-synuclein biochemical and pathological diversity.

Authors:  Hilal A Lashuel; Anne-Laure Mahul-Mellier; Salvatore Novello; Ramanath Narayana Hegde; Yllza Jasiqi; Melek Firat Altay; Sonia Donzelli; Sean M DeGuire; Ritwik Burai; Pedro Magalhães; Anass Chiki; Jonathan Ricci; Manel Boussouf; Ahmed Sadek; Erik Stoops; Christian Iseli; Nicolas Guex
Journal:  NPJ Parkinsons Dis       Date:  2022-10-20

5.  The effect of truncation on prion-like properties of α-synuclein.

Authors:  Makoto Terada; Genjiro Suzuki; Takashi Nonaka; Fuyuki Kametani; Akira Tamaoka; Masato Hasegawa
Journal:  J Biol Chem       Date:  2018-07-20       Impact factor: 5.157

Review 6.  Animal models of Parkinson's disease: limits and relevance to neuroprotection studies.

Authors:  Erwan Bezard; Zhenyu Yue; Deniz Kirik; Maria Grazia Spillantini
Journal:  Mov Disord       Date:  2012-07-02       Impact factor: 10.338

7.  Caspase-1 causes truncation and aggregation of the Parkinson's disease-associated protein α-synuclein.

Authors:  Wei Wang; Linh T T Nguyen; Christopher Burlak; Fariba Chegini; Feng Guo; Tim Chataway; Shulin Ju; Oriana S Fisher; David W Miller; Debajyoti Datta; Fang Wu; Chun-Xiang Wu; Anuradha Landeru; James A Wells; Mark R Cookson; Matthew B Boxer; Craig J Thomas; Wei Ping Gai; Dagmar Ringe; Gregory A Petsko; Quyen Q Hoang
Journal:  Proc Natl Acad Sci U S A       Date:  2016-08-01       Impact factor: 11.205

8.  Inhibition of calpain prevents manganese-induced cell injury and alpha-synuclein oligomerization in organotypic brain slice cultures.

Authors:  Bin Xu; Wei Liu; Yu Deng; Tian-Yao Yang; Shu Feng; Zhao-Fa Xu
Journal:  PLoS One       Date:  2015-03-10       Impact factor: 3.240

Review 9.  Mitochondria and α-Synuclein: Friends or Foes in the Pathogenesis of Parkinson's Disease?

Authors:  Gaia Faustini; Federica Bono; Alessandra Valerio; Marina Pizzi; PierFranco Spano; Arianna Bellucci
Journal:  Genes (Basel)       Date:  2017-12-08       Impact factor: 4.096

10.  Toll-like receptor 4 is required for α-synuclein dependent activation of microglia and astroglia.

Authors:  Lisa Fellner; Regina Irschick; Kathrin Schanda; Markus Reindl; Lars Klimaschewski; Werner Poewe; Gregor K Wenning; Nadia Stefanova
Journal:  Glia       Date:  2012-10-25       Impact factor: 7.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.